title: [Fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache].
abstract: Efficacy of antidepressants fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache has been studied. Amitriptyline had the highest effect in dosage 50 mg daily but was not well tolerated by patients that resulted in that only 50% of them finished the study. Fluvoxamine had high efficacy and good tolerability in the treatment of chronic daily headache and medication overuse headache. Small dosages of amitriptyline and fluvoxamine potentiated the analgesic effect of transcranial electrostimulation of the brain. The combination of antidepressants with transcranial electrostimulation of the brain alleviated the negative effect of the withdrawal of overused analgesics and may be recommended for out-patient use.
authors.forename: S V
authors.initials: SV
authors.lastname: Tarasova
authors.forename: A V
authors.initials: AV
authors.lastname: Amelin
authors.forename: A A
authors.initials: AA
authors.lastname: Skoromets
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D000328:Adult; D000639:Amitriptyline / Q000627:therapeutic use*; D002908:Chronic Disease; D004599:Electric Stimulation Therapy / Q000295:instrumentation*; D005260:Female; D016666:Fluvoxamine / Q000627:therapeutic use*; D006261:Headache / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D012886:Skull
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000639:Amitriptyline; D016666:Fluvoxamine; D017367:Selective Serotonin Reuptake Inhibitors